<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">The Zika virus (ZIKAV) was considered harmless until the Guillain-Barré syndrome and other autoimmune complications were shown to be associated with the infection during the French Polynesia outbreak in 2013–2014 [
 <xref ref-type="bibr" rid="CR1">1</xref>]. The 2015 Latin America and the Caribbean (LAC) outbreak increased its scientific and public health interest worldwide [
 <xref ref-type="bibr" rid="CR2">2</xref>]. Over one million people were infected in the region, with a shocking number of microcephaly cases in fetuses and infants [
 <xref ref-type="bibr" rid="CR3">3</xref>, 
 <xref ref-type="bibr" rid="CR4">4</xref>]. Given the epidemic extension and the identification of ZIKAV as the causal link of congenital neurodevelopmental defects, the World Health Organization (WHO) recognized the ZIKAV infection as a public health emergency of international concern (PHEIC) [
 <xref ref-type="bibr" rid="CR5">5</xref>]. In 2017, it was estimated that the ZIKAV disease was responsible for 2.24 thousand disability-adjusted life years (DALY) globally [
 <xref ref-type="bibr" rid="CR6">6</xref>].
</p>
